IMMAGE BIOTHERAPEUTICS CORP. Research and Development Expense
IMMAGE BIOTHERAPEUTICS CORP. reported Research and Development Expense of $5.69 thousand for the 3-month period ending 2017-02-28, per its 10-Q filed 2017-04-19.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2017-04-19
- IMMAGE BIOTHERAPEUTICS CORP. research and development expense for the quarter ending 2017-02-28 was $5.69K, a 83.58% decline year-over-year.
- IMMAGE BIOTHERAPEUTICS CORP. research and development expense for the quarter ending 2016-11-30 was $1.63M.
- IMMAGE BIOTHERAPEUTICS CORP. research and development expense for the quarter ending 2016-08-31 was $17.83K.
- IMMAGE BIOTHERAPEUTICS CORP. research and development expense for the quarter ending 2016-05-31 was $9.71K.
- IMMAGE BIOTHERAPEUTICS CORP. research and development expense for fiscal 2016 was $62.22K.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2017-02-28 | $5.69K 10-Q · filed 2017-04-19 | $1.63M 10-Q · filed 2017-04-19 | $1.65M derived: sum of 3 quarters · filed 2017-04-19 | $1.66M derived: sum of 4 quarters · filed 2017-04-19 |
| 2016-11-30 | $1.63M 10-Q · filed 2017-01-06 | $1.64M derived: sum of 2 quarters · filed 2017-01-06 | $1.65M derived: sum of 3 quarters · filed 2017-01-06 | $1.69M derived: sum of 4 quarters · filed 2017-04-19 |
| 2016-08-31 | $17.83K derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-08 | $27.55K derived: sum of 2 quarters · filed 2016-12-08 | $62.22K derived: sum of 3 quarters · filed 2017-04-19 | $62.22K 10-K · filed 2016-12-08 |
| 2016-05-31 | $9.71K 10-Q · filed 2016-07-15 | $44.39K derived: sum of 2 quarters · filed 2017-04-19 | $44.39K 10-Q · filed 2016-07-15 | |
| 2016-02-29 | $34.67K 10-Q · filed 2016-04-14 | $34.67K 10-Q · filed 2016-04-14 |